HOME     RESEARCH     SERVICES     TRANSLATIONAL RESEARCH     PERSONNEL     PUBLICATIONS     NEWS     CONTACT
 
 
 
The Jewish General Hospital Proteomics Centre encompasses the Segal Cancer Proteomics Centre (SCPC) and the Warren Y. Soper Program in Translational Proteomics. The SCPC applies state-of-the-art quantitative mass spectrometry-based proteomics and metabolomics methods for research, provides services to the academic, pharmaceutical and biotechnology groups, and translates quantitative mass spectrometry assays to the clinic.
 
 
Research
• (Fundamental) method     development
• MultiOMICS for personalized  medicine
• Proteogeonomics 
 
 
Translation
 • Targeted MS assays for the clinic
 
  
 Services
• Identification of PTMs
• Relative quantitative proteomics and phosphoproteomics
• Targeted quantitative MS proteomics & metabolomics
• MultiOMICS
• Protein-protein interactions
 
Our technologies can be applied to a wide range of samples, from purified proteins and protein complexes to biofluids, cells, biopsies and FFPE tissues, requiring only minimal sample amounts (e.g. few µL of blood; few µg of total protein from cells and tissues). 
 
                                                                               
 
 The Segal Cancer Proteomics Centre is part of two Pan-Canadian networks, TMIC (The Metabolomics Innovation Centre) and PCPC (Pan-Canadian Proteomics Centre)
 
Support research at the Lady Davis Institute - Jewish General Hospital